Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Apr. 01, 2016
Cash flow from operating activities:
Net Income (loss)	$ 751	$ (20,857)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization expense	387	420
Equity-based compensation expense	283	377
Deferred income taxes	569	(224)
Deferred compensation	4	45
Goodwill impairment		21,544
Changes in assets and liabilities:
(Increase) decrease in accounts receivable	4,221	(3,232)
Increase in prepaid and other current assets	(344)	(917)
Increase in cash surrender value of life insurance	(109)	(143)
Decrease in accounts payable	(380)	(2,226)
Increase in accrued compensation	3,235	4,524
Increase in advance billings on contracts	1,235	923
Decrease in other current liabilities	(1,061)	(44)
Increase (decrease) in income taxes payable	(342)	346
Increase in other long-term liabilities	13	54
Net cash provided by operating activities	8,462	590
Cash flow from investing activities:
Additions to property and equipment	(156)	(816)
Additions to capitalized software	(602)	(147)
Deferred compensation plan investments, net	(45)	(166)
Net cash used in investing activities	(803)	(1,129)
Cash flow from financing activities:
Proceeds from (payments on) long-term debt, net	(4,725)	295
Proceeds from stock option plan exercises	77	121
Excess tax benefits from equity-based compensation		14
Taxes remitted for shares withheld from equity-based compensation transactions	(246)	(291)
Proceeds from Employee Stock Purchase Plan	37	52
Change in cash overdraft, net	(347)	(468)
Dividends paid		(925)
Purchase of stock for treasury	(1,886)
Net cash used in financing activities	(7,090)	(1,202)
Effect of exchange rates on cash and cash equivalents	129	372
Net increase (decrease) in cash and cash equivalents	698	(1,369)
Cash and cash equivalents at beginning of year	9,407	10,801
Cash and cash equivalents at end of quarter	$ 10,105	$ 9,432